Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127076752 | 12707675 | 2 | F | 20160422 | 20160907 | 20160901 | 20160919 | EXP | FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-070703 | BRISTOL MYERS SQUIBB | 1.46 | YR | M | Y | 0.00000 | 20160919 | CN | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127076752 | 12707675 | 1 | PS | ETOPOPHOS | ETOPOSIDE PHOSPHATE | 1 | Intravenous (not otherwise specified) | 50 MG, QD | 150 | MG | U | 20457 | 50 | MG | POWDER FOR INJECTION | QD | |||
| 127076752 | 12707675 | 2 | SS | IFOSFAMIDE EG | IFOSFAMIDE | 1 | Intravenous (not otherwise specified) | 1 G, UNK | U | 0 | 1 | G | |||||||
| 127076752 | 12707675 | 3 | SS | VINCRISTINE HOSPIRA | VINCRISTINE | 1 | Intravenous (not otherwise specified) | 0.5 MG, QD | 1 | MG | U | 0 | .5 | MG | QD | ||||
| 127076752 | 12707675 | 4 | SS | DOXORUBICINE TEVA | DOXORUBICIN | 1 | Intravenous (not otherwise specified) | 6.8 MG, QD | 14 | MG | U | 0 | 6.8 | MG | QD | ||||
| 127076752 | 12707675 | 5 | C | SODIUM BICARBONATE. | SODIUM BICARBONATE | 1 | Unknown | U | 0 | ||||||||||
| 127076752 | 12707675 | 6 | C | MYCOSTATINE | NYSTATIN | 1 | Unknown | U | 0 | ||||||||||
| 127076752 | 12707675 | 7 | C | GRANOCYTE | LENOGRASTIM | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127076752 | 12707675 | 1 | Ewing's sarcoma |
| 127076752 | 12707675 | 2 | Ewing's sarcoma |
| 127076752 | 12707675 | 3 | Ewing's sarcoma |
| 127076752 | 12707675 | 4 | Ewing's sarcoma |
| 127076752 | 12707675 | 5 | Product used for unknown indication |
| 127076752 | 12707675 | 6 | Product used for unknown indication |
| 127076752 | 12707675 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127076752 | 12707675 | HO |
| 127076752 | 12707675 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127076752 | 12707675 | Encephalopathy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127076752 | 12707675 | 1 | 20160420 | 20160422 | 0 | |
| 127076752 | 12707675 | 2 | 20160420 | 20160421 | 0 | |
| 127076752 | 12707675 | 3 | 20160420 | 20160421 | 0 | |
| 127076752 | 12707675 | 4 | 20160420 | 20160421 | 0 |